If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,790.00    6.00 (0.34%)
Bid:
1,774.00
Ask:
1,780.00
Spread: 6.00 (0.338%)
Market Cap: £527.18m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Post Close Trading Update

13 Oct 2021 07:00

RNS Number : 8651O
Avon Protection PLC
13 October 2021
 

13 October 2021

Avon Protection plc

Post Close Trading Update

 

Avon Protection plc ("Avon" or the "Group") today provides the following post close trading update for its financial year ended 30 September 2021 ("FY21").

 

Trading update

Avon has continued to see good commercial momentum in the second half of FY21, with order intake for the year of c.$280 million. This represents total year-on-year order growth of 34% and growth of 15% excluding Team Wendy. As a result, the Group has carried a strong closing order book of $141 million into the new financial year ("FY22"), up 39% on 30 September 2020. This momentum underpins confidence in the Group's growth expectations for FY22.

 

The Group expects to report revenue of $250 million for FY21 (2020: $213.6 million), which is within the range indicated in our trading update of 13 August 2021. This includes a Team Wendy contribution of $41 million from the first 11 months of ownership, in line with expectations at the time of acquisition.

 

As expected, we have seen revenue growth in our First Responder business and Military respiratory portfolio, offset by declines in Military ballistic revenue due to the previously announced delays. Overall, Military revenue is expected to decline by 3% to $149 million with respiratory revenue growth of 10% being offset by a 31% decline in Military ballistic revenues. First Responder revenues are expected to have increased by 2% to $61 million, against a strong comparator in 2020, driven by very encouraging growth in our ballistic protection portfolio.

 

Trading profitability in the remainder of FY21 was in line with the expectations set out in the August trading update. The Group will however recognise one-off, non-cash, ballistic protection inventory adjustments, which are expected to reduce the reported adjusted EBITDA margin for FY21 to between 15% and 16%.

 

Cash conversion has come through more strongly than anticipated at the time of the August trading update. As a result, we expect FY21 reported cash conversion of c.80% and net debt before lease liabilities of $27 million at 30 September 2021.

 

Commenting, Paul McDonald, Chief Executive Officer, said:

"We have made considerable commercial progress over the last 12 months in continuing to build a broader portfolio of contracts, increasing our pipeline of opportunities and making record levels of investment in the business.

 

We carry significant commercial momentum into FY22, which will also benefit from a strong ramp-up in body armor, as well as the strengthened senior management, processes and infrastructure we have put in place over the past year whilst navigating the ongoing disruption related to Covid through our supply chains.

 

We remain well set for growth in FY22 and beyond and are as confident as ever about the medium-term prospects of Avon Protection. This is underpinned by a strong order book, a growing and visible contract pipeline and our global market leading positions in respiratory and ballistic protection."

 

Notice of Results

The Group will release its results for the year ended 30 September 2021 on 23 November 2021.

 

For further enquiries, please contact:

 

Avon Protection plc

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

Rachel Stevens, Director of Investor Relations

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Note to editors: 

Avon Protection plc is listed on the London Stock Exchange (LSE: AVON) and is an innovative technology group, which designs and produces life critical personal protection systems to maximise the performance and capabilities of its customers, with leading positions in the respiratory and ballistic protection markets for the world's militaries and first responders.

For further information, please visit our website www.avon-protection-plc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETIDLFLIL
Date   Source Headline
7th Jul 20214:00 pmRNSDirector/PDMR Shareholding
10th Jun 20213:00 pmRNSHolding(s) in Company
9th Jun 202110:00 amRNSDirector/PDMR Shareholding
27th May 20212:00 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSBoard change
25th May 20217:00 amRNSInterim Results
6th May 20211:00 pmRNSDirector/PDMR Shareholding
16th Apr 20212:00 pmRNSHolding(s) in Company
13th Apr 20216:00 pmRNSHolding(s) in Company
13th Apr 20214:00 pmRNSHolding(s) in Company
9th Apr 20217:00 amRNSHalf Year Trading Update
7th Apr 20212:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSU.S. Army Ballistic Helmet Order
18th Mar 20216:00 pmRNSDirector/PDMR Shareholding
8th Mar 20214:00 pmRNSDirector/PDMR Shareholding
5th Mar 20215:00 pmRNSHolding(s) in Company
8th Feb 20215:00 pmRNSDirectors'/PDMR Shareholdings
4th Feb 20217:00 amRNSHolding(s) in Company
3rd Feb 20215:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20213:00 pmRNSNon-Executive Director update
29th Jan 202112:00 pmRNSResult of AGM
29th Jan 20217:00 amRNSAnnual General Meeting - Trading Update
18th Jan 20217:00 amRNSHolding(s) in Company
15th Jan 20212:00 pmRNSDirector/PDMR Shareholding
7th Jan 202110:00 amRNSDirector/PDMR Shareholdings
22nd Dec 20202:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20202:00 pmRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSNATO Support & Procurement Agency Order
17th Dec 20207:00 amRNSContract delay and trading update
16th Dec 20205:45 pmRNSAnnual Report and Accounts and Notice of AGM
9th Dec 20205:00 pmRNSDirectors’ and PDMRs’ Interest in Shares
9th Dec 20204:00 pmRNSHolding(s) in Company
8th Dec 20204:00 pmRNSDirectors'/PDMR Shareholdings
7th Dec 20207:00 amRNSHolding(s) in Company
3rd Dec 20206:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20207:00 amRNSFinal Results
1st Dec 20205:15 pmRNSHolding(s) in Company
20th Nov 202011:00 amRNSBoard Update
11th Nov 20207:00 amRNSHolding(s) in Company
6th Nov 202012:00 pmRNSDirectors'/PDMR Shareholdings
6th Nov 202010:00 amRNSNotice of revised date for Preliminary Results
5th Nov 20202:00 pmRNSHolding(s) in Company
3rd Nov 20203:00 pmRNSHolding(s) in Company
3rd Nov 20207:00 amRNSCOMPLETION OF TEAM WENDY ACQUISITION
26th Oct 20207:00 amRNSSATISFACTION OF HSR CONDITION
22nd Oct 202012:00 pmRNSNotice of Results
6th Oct 20203:00 pmRNSHolding(s) in Company
6th Oct 202011:00 amRNSDirectors'/PDMR Shareholdings
28th Sep 20209:30 amRNSACQUISITION - RESULTS OF GENERAL MEETING
25th Sep 202011:00 amRNSCompletion of divestment of milkrite | InterPuls

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.